InsidersTradesSigma
Follow the Jagsonpal Pharmaceuticals Limited stock price and the full directors' dealings record of the company, a listed equity based in India. Shares are listed on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Jagsonpal Pharmaceuticals Limited has logged 3 public disclosures. Market capitalisation: €15.2bn. The latest transaction was disclosed on 27 June 2022 (Sale). Among the most active insiders: ARESKO PREGRESSIVE PVT. LTD. As partner J & P Investments Partnership. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Jagsonpal Pharmaceuticals Limited 是一家印度制药公司，从事药品的制造和分销。该公司在孟买证券交易所上市。